Complement-associated neuronal loss in a patient with CASPR2 antibody–associated encephalitis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 19, 2014
- Accepted in final form December 30, 2014
- First Published February 12, 2015.
Author Disclosures
- Peter Körtvelyessy, MD*,
- Jan Bauer, PhD*,
- Christian M. Stoppel, MD, PhD,
- Wolfgang Brück, MD,
- Ivonne Gerth, MA,
- Stefan Vielhaber, MD,
- Falk R. Wiedemann, MD,
- Hans J. Heinze, MD,
- Claudius Bartels, MD and
- Christian G. Bien, MD
- Peter Körtvelyessy, MD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jan Bauer, PhD*,
SAB of the dutch foundation for Multiple Sclerosis research (non-profit entity)
NONE
NONE
NONE
NONE
NONE
Dept of Neuroimmunology, Center for Brain Research. Medical University of Vienna. Associate Professor
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christian M. Stoppel, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Wolfgang Brück, MD,
I serve on the advisory board of Genzyme, Novartis, Biogen Idec Germany and Teva Pharma.
NONE
I received honoraria for oral presentations from Teva, Sanofi, Genzyme, Novartis, Merck-Serono, Biogen Idec and Bayer in the last 2 years.
I am editorial board member of Acta neuropathologica, Therapeutic Advances in Neurological disorders, Multiple Sclerosis International and Neuropathology and Applied Neurobiology
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
German Research foundation (DFG SFB TR43): The brain as a target of inflammatory processes, 2008-2015 German ministry for science and education: Competence network multiple sclerosis, 2010-2015
NONE
Tschira Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Ivonne Gerth, MA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stefan Vielhaber, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Falk R. Wiedemann, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hans J. Heinze, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Claudius Bartels, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christian G. Bien, MD
Serving on a scientific advisory board for Eisai and UCB, Germany Travel funded by a commercial entity: Grifols, UCB, Eisai, GlaxoSmithKline, Desitin Honoraria for speaking engagements from Desitin, GlaxoSmithKline, UCB, Eisai
NONE
Commercial entities: UCB Pharma, Desitin Pharma, Eisai Pharma, biogen idec, Fresenius Medical Care, diamed -honoraria for speaking on educational courses Non-profit entities: Rasmussen encephalitis children project (Mr Seth Wohlberg) for travel and lodging to two Rasmussen encephalitis workshops in the USA
NONE
NONE
NONE
NONE
for UCB
NONE
NONE
Epilepsy-Centre Bielefeld-Bethel, 100% clinical practice
(1) Fresenius Medical Care, Homburg, Germany (2) diamed, K?ln, Germany
NONE
Academic entity University of Bonn, Dept. of Epileptology, Bonn, Germany (where I was employed until 31st Dec, 2010)
Hagedorn Foundation Bielefeld
NONE
NONE
The Krankenhaus Mara gGmbH receives payment for antibody tests (antineural antibodies) performed in the laboratory run by CGB.
NONE
NONE
NONE
- From the Department of Neurology (P.K., I.G., S.V., H.J.H., C.B.), University Clinic Magdeburg, Germany; Department of Neuroimmunology (J.B.), Center for Brain Research, Medical University of Vienna, Austria; Department of Psychiatry and Psychotherapy (C.M.S.), Charité University Hospital, Berlin, Germany; Department of Neuropathology (W.B.), University Medical Center Göttingen, Germany; Department of Neurology (F.R.W.), Median Clinic NRZ Magdeburg, Germany; and Epilepsy Center Bethel (C.G.B.), Krankenhaus Mara, Bielefeld, Germany.
- Correspondence to Dr. Körtvelyessy: peter.koertvelyessy{at}med.ovgu.de
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.